Cannabis researcher MMJ International Holdings Corp (MMJ) continues to fight with the Drug Enforcement Administration (DEA) over a bulk manufacturing application that was submitted almost five years ago, and never processed. Megan Sheehan of Sheehan & Associates, representing MMJ, sent a warning letter to the DEA deputy assistant administrator Matthew Strait, and DEA regulatory chief Ricardo Quintero, Benzinga learned. DEA "Operating Against The Law" "My client has submitted a bulk manufacturing application (W18134021E) for research and pharmaceutical development purposes on December 27, 2018, and your agency has still not processed the application in question," the letter exclusively procured by Benzinga reads. "This inaction is in violation of the Controlled Substance Act ("CSA"), the Marijuana and Cannabidiol Research Expansion Act ("MCREA"), and Drug Enforcement Agency ("DEA") policies and procedures."